Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

Trading Statement

1 Sep 2022 07:00

RNS Number : 8490X
Directa Plus PLC
01 September 2022
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 (as amended). Upon the publication of this announcement, this inside information is now considered to be in the public domain

 

1 September 2022

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Trading Update and Notice of Results

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to provide a trading update ahead of the announcement of its half year results for the six months to 30 June 2022 on 29 September 2022.

 

Trading

Further to the AGM statement announcement on 17 June 2022, Directa Plus continues to perform strongly and has delivered robust H1 2022 results across all verticals. As a result, based on its unaudited management accounts, the Company now expects to report that total revenues for H1 2022 have grown c.39% to €5.5m (H1 2021: €3.95m), driven by strong performance across all verticals.

 

Despite the uncertainty in the macro-economic climate caused by the Ukraine war, rising inflation driven by energy cost increases, and fears of recession, the Company continues to generate growing interest and awareness from global players across its different verticals.

 

The Company is responding to the inflation trends, which in H1 2022 led to cost increases and a reduction in margins. The Company has invested in manufacturing equipment which the Board expects to deliver productivity gains and margin efficiencies in H2 that will materially reduce direct production costs.

 

The Board is confident of the Company's continued growth trend and expects to deliver revenue growth of greater than 40% year-on-year (FY2021: €8.6m).

 

Environmental Remediation

Directa Plus still awaits the final decision on the award of a significant tender in Romania for its Environmental Remediation services, and the Directors continue to believe that the Company is well positioned to win the tender.

 

The Commercial Agreement with REDA Energy Ltd to distribute Grafysorber Products continues to progress with a second order received alongside an introduction to a significant potential new customer.

 

Further Opportunities

The Company continues to deliver enhancements, based on its patented technology, to products in other areas where Directa Plus has identified significant potential commercial opportunities, including paints, water/air filtration, Lithium-Sulphur batteries and composites.

 

The Company continues to partner with leading worldwide suppliers to develop outstanding products, as highlighted by the recent patent awards for filtration, the Notice of Allowance received from the United States Patent and Trademark Office for G+® embedded polyurethane membranes, alongside the extension of the partnership with Alfredo Grassi.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "We are pleased with the growth and commercial progress we have achieved in the first half of the year. Directa Plus continues to gain momentum in this uncertain and challenging market and continues to make progress to commercialise our highly valuable IP portfolio. The fundraise completed in December 2021 has allowed us to accelerate growth, reduce production costs, and to develop the pipeline where we see many exciting opportunities."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Giorgio Bonfanti, CFO

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald

Adam Rae

 

Singer Capital Markets Securities Limited (Joint Broker)

+44 20 7496 3069

Rick Thompson

Phil Davies

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson

 

Heather Armstrong

 

 

Notes to Editors

 

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.

 

Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+(R)) have multiple applications due to its properties. These G+(R) products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. Directa Plus holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSDFESFEESEDA
Date   Source Headline
18th Oct 201911:36 amRNSResult of Open Offer, and GM, Issue of Equity
30th Sep 20192:21 pmRNSAcquisition, Placing and Open Offer
30th Sep 20192:21 pmRNSHalf-year Report
10th Sep 20197:00 amRNSNew Textile Membrane Patent Granted
6th Aug 20198:29 amRNSHolding(s) in Company
29th Jul 20197:00 amRNSAward of Oil Decontamination and Recovery Contract
22nd Jul 20197:00 amRNSHolding(s) in Company
4th Jul 20197:00 amRNSUS Patent Grant for Liquid G+
27th Jun 20197:00 amRNSGrant of US Patent
26th Jun 20199:47 amRNSHolding(s) in Company
18th Jun 20191:36 pmRNSResult of AGM
18th Jun 20197:00 amRNSAGM Statement
17th Jun 20197:00 amRNSHolding(s) in Company
28th May 20197:00 amRNSDirector/PDMR Shareholding
23rd May 20197:00 amRNSNew patent grants
23rd May 20197:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20197:00 amRNSCo-operation agreement with Alfredo Grassi S.p.A.
17th Apr 20197:00 amRNSFinal Results for the Year to 31 December 2018
1st Apr 20197:00 amRNSSuccessful First Road Surface Trial Results
4th Mar 20197:00 amRNS3 Year Exclusive Agreement with Loro Piana
6th Feb 20197:00 amRNSUS National Graphene Association Appointment
31st Jan 20194:41 pmRNSHolding(s) in Company
31st Jan 20199:05 amRNSSecond Price Monitoring Extn
31st Jan 20199:00 amRNSPrice Monitoring Extension
30th Jan 20193:45 pmRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
30th Jan 201911:00 amRNSHolding(s) in Company
8th Jan 201911:58 amRNSResult of General Meeting and Total Voting Rights
7th Jan 20191:00 pmRNSResults of Open Offer
13th Dec 20187:00 amRNSAnnouncement of Open Offer
12th Dec 20183:30 pmRNSResults of Placing
12th Dec 201811:30 amRNSProposed Placing to raise a minimum of £3 million
5th Dec 20187:00 amRNSDirecta Plus to present at Denim Première Vision
29th Nov 20187:00 amRNSCollaboration Agreement with Ambienthesis S.p.A.
23rd Nov 20184:00 pmRNSDirecta Plus to present at Mello London
23rd Nov 20187:00 amRNSEnvironmental Sale and Participation in Trial
22nd Nov 20187:00 amRNSTrading Update
30th Oct 20189:15 amRNSFurther Agreement with Arvind, Launch of G+ Jeans
23rd Oct 20187:00 amRNSSignificant Textiles Order
28th Sep 201812:55 pmRNSDirector/PDMR Shareholding
26th Sep 20182:24 pmRNSReplacement: Director/PDMR Shareholding
26th Sep 201812:52 pmRNSDirector/PDMR Shareholding
26th Sep 20187:00 amRNSWorld's First Road Surface Containing Graphene
25th Sep 20187:00 amRNSHalf-year Report
31st Jul 20187:00 amRNSAppointment of N+1 Singer as Joint Broker
9th Jul 201810:00 amRNSOakley and Bioracer launch Graphene Plus jersey
4th Jul 20187:00 amRNSSecond significant order from Alfredo Grassi
18th Jun 20184:28 pmRNSResult of AGM
18th Jun 20187:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.